TFDA-2024-0011-V311

Type IA variation for application TFDA-2024-0011. Type IA variation: Manufacturing Process Change for Infectivir — critical change

Variation Number
TFDA-2024-0011-V311
Type
Type IA
Application
TFDA-2024-0011
Change
CHG-2022-0011
Status
Pending
Fee
€3,503
Submitted
2022-08-24
Approved
—
Description

Type IA variation: Manufacturing Process Change for Infectivir — critical change